TEVA
Price
$18.89
Change
-$1.04 (-5.22%)
Updated
Sep 15, 04:59 PM (EDT)
Capitalization
22.72B
52 days until earnings call
Interact to see
Advertisement

TEVA

Header iconTEVA Comparison
Open Charts TEVABanner chart's image
Teva Pharmaceutical Industries
Price$18.89
Change-$1.04 (-5.22%)
Volume$134.5K
Capitalization22.72B
TEVA Comparison Chart in %
Loading...
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), BioCryst Pharmaceuticals (NASDAQ:BCRX), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Tilray Brands (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 3.94B. The market cap for tickers in the group ranges from 5.57K to 65.68B. ZTS holds the highest valuation in this group at 65.68B. The lowest valued company is BGPPF at 5.57K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was 0%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 40%. MILFF experienced the highest price growth at 82%, while BUDZ experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was -36%. For the same stocks of the Industry, the average monthly volume growth was -53% and the average quarterly volume growth was -39%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 65
Price Growth Rating: 55
SMR Rating: 83
Profit Risk Rating: 91
Seasonality Score: -21 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (TEVA: $19.93)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TEVA’s FA Score shows that 1 FA rating(s) are green while.

  • TEVA’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TEVA’s TA Score shows that 6 TA indicator(s) are bullish.

  • TEVA’s TA Score: 6 bullish, 4 bearish.

Price Growth

TEVA (@Pharmaceuticals: Generic) experienced а +5.17% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.21%. For the same industry, the average monthly price growth was +6.07%, and the average quarterly price growth was +39.76%.

Reported Earning Dates

TEVA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.21% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TEVA
Capitalization22.7B
EBITDA1.9B
Gain YTD-9.574
P/E RatioN/A
Revenue16.6B
Total Cash2.16B
Total Debt17.5B
FUNDAMENTALS RATINGS
TEVA: Fundamental Ratings
TEVA
OUTLOOK RATING
1..100
42
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
51
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TEVA
RSI
ODDS (%)
Bearish Trend 4 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
67%
Momentum
ODDS (%)
Bullish Trend 4 days ago
74%
MACD
ODDS (%)
Bullish Trend 6 days ago
66%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
68%
Advances
ODDS (%)
Bullish Trend 4 days ago
72%
Declines
ODDS (%)
Bearish Trend 19 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
77%
Aroon
ODDS (%)
Bullish Trend 4 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ZTOP52.660.17
+0.33%
F/m High Yield 100 ETF
EQRR63.56N/A
N/A
ProShares Equities for Rising Rates ETF
PFIG24.39-0.03
-0.12%
Invesco Fdmtl Invmt Grd Corp Bd ETF
SHYD22.92-0.05
-0.22%
VanEck Short High Yield Muni ETF
WTV91.27-0.85
-0.92%
WisdomTree US Value ETF

TEVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TEVA has been loosely correlated with AMRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TEVA jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TEVA
1D Price
Change %
TEVA100%
+0.20%
AMRX - TEVA
40%
Loosely correlated
-0.89%
VTRS - TEVA
32%
Poorly correlated
-2.06%
ELAN - TEVA
30%
Poorly correlated
-1.33%
SNDL - TEVA
26%
Poorly correlated
+0.84%
ACET - TEVA
25%
Poorly correlated
-8.14%
More